Clinical Trial Update: Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Volrustomig in women with high-risk locally advanced cervical cancer is currently recruiting (eVOLVE-Cervical), sponsored by AstraZen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Volrustomig

Snippet

Sponsor: AstraZeneca | Conditions: Locally Advanced Cervical Cancer | Phase 3 | Status: RECRUITING